MDXG logo

MiMedx Group, Inc. (MDXG) EBITDA

annual EBITDA:

$62.35M+$21.81M(+53.80%)
December 31, 2024

Summary

  • As of today (August 30, 2025), MDXG annual EBITDA is $62.35 million, with the most recent change of +$21.81 million (+53.80%) on December 31, 2024.
  • During the last 3 years, MDXG annual EBITDA has risen by +$61.16 million (+5139.92%).
  • MDXG annual EBITDA is now at all-time high.

Performance

MDXG EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDXGincome statement metrics

quarterly EBITDA:

$15.53M+$4.08M(+35.62%)
June 30, 2025

Summary

  • As of today (August 30, 2025), MDXG quarterly EBITDA is $15.53 million, with the most recent change of +$4.08 million (+35.62%) on June 30, 2025.
  • Over the past year, MDXG quarterly EBITDA has dropped by -$8.68 million (-35.85%).
  • MDXG quarterly EBITDA is now -38.41% below its all-time high of $25.22 million, reached on December 31, 2017.

Performance

MDXG quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDXGincome statement metrics

TTM EBITDA:

$51.13M-$8.68M(-14.52%)
June 30, 2025

Summary

  • As of today (August 30, 2025), MDXG TTM EBITDA is $51.13 million, with the most recent change of -$8.68 million (-14.52%) on June 30, 2025.
  • Over the past year, MDXG TTM EBITDA has dropped by -$15.35 million (-23.09%).
  • MDXG TTM EBITDA is now -23.40% below its all-time high of $66.74 million, reached on September 30, 2024.

Performance

MDXG TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDXGincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

MDXG EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+53.8%-35.9%-23.1%
3 y3 years+5139.9%+287.4%+555.9%
5 y5 years+611.9%+496.7%+2468.0%

MDXG EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+683.8%-35.9%+287.4%-23.4%+360.0%
5 y5-yearat high+270.7%-35.9%+217.3%-23.4%+239.9%
alltimeall timeat high+270.7%-38.4%+204.0%-23.4%+239.9%

MDXG EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$15.53M(+35.6%)
$51.13M(-14.5%)
Mar 2025
-
$11.45M(-3.8%)
$59.81M(-4.1%)
Dec 2024
$62.35M(+53.8%)
$11.90M(-2.7%)
$62.35M(-6.6%)
Sep 2024
-
$12.23M(-49.5%)
$66.74M(+0.4%)
Jun 2024
-
$24.22M(+73.0%)
$66.47M(+23.2%)
Mar 2024
-
$14.00M(-14.1%)
$53.98M(+33.1%)
Dec 2023
$40.54M(-479.6%)
$16.29M(+36.1%)
$40.54M(+52.3%)
Sep 2023
-
$11.97M(+2.1%)
$26.62M(+199.9%)
Jun 2023
-
$11.72M(+1977.5%)
$8.88M(-179.8%)
Mar 2023
-
$564.00K(-76.2%)
-$11.13M(-43.4%)
Dec 2022
-$10.68M(-997.6%)
$2.37M(-141.1%)
-$19.67M(+13.8%)
Sep 2022
-
-$5.78M(-30.3%)
-$17.27M(+54.0%)
Jun 2022
-
-$8.29M(+4.0%)
-$11.21M(+614.3%)
Mar 2022
-
-$7.97M(-267.4%)
-$1.57M(-232.2%)
Dec 2021
$1.19M(-103.3%)
$4.76M(+1571.6%)
$1.19M(-107.1%)
Sep 2021
-
$285.00K(-79.0%)
-$16.82M(-32.1%)
Jun 2021
-
$1.35M(-126.0%)
-$24.75M(-17.6%)
Mar 2021
-
-$5.21M(-60.6%)
-$30.02M(-17.8%)
Dec 2020
-$36.53M(+199.9%)
-$13.24M(+73.1%)
-$36.53M(+40.0%)
Sep 2020
-
-$7.65M(+95.3%)
-$26.10M(+1108.8%)
Jun 2020
-
-$3.92M(-66.6%)
-$2.16M(-83.6%)
Mar 2020
-
-$11.73M(+318.3%)
-$13.18M(+7.8%)
Dec 2019
-$12.18M(-507.2%)
-$2.80M(-117.2%)
-$12.22M(+29.8%)
Sep 2019
-
$16.29M(-209.0%)
-$9.42M(-60.2%)
Jun 2019
-
-$14.94M(+38.7%)
-$23.66M(+329.9%)
Mar 2019
-
-$10.77M(-625.9%)
-$5.50M(-115.8%)
Dec 2018
$2.99M(-94.2%)
-
-
Sep 2018
-
$2.05M(-36.4%)
$34.93M(-19.1%)
Jun 2018
-
$3.22M(-27.6%)
$43.16M(-11.5%)
Mar 2018
-
$4.44M(-82.4%)
$48.77M(-8.1%)
Dec 2017
$51.99M(+108.0%)
$25.22M(+145.5%)
$53.08M(+40.6%)
Sep 2017
-
$10.27M(+16.3%)
$37.74M(+11.4%)
Jun 2017
-
$8.84M(+1.0%)
$33.88M(+12.9%)
Mar 2017
-
$8.74M(-11.6%)
$30.01M(+20.1%)
Dec 2016
$24.99M
$9.89M(+54.3%)
$24.99M(+5.7%)
Sep 2016
-
$6.41M(+29.0%)
$23.64M(-4.1%)
Jun 2016
-
$4.97M(+33.4%)
$24.65M(-5.2%)
DateAnnualQuarterlyTTM
Mar 2016
-
$3.72M(-56.4%)
$25.99M(-4.1%)
Dec 2015
$27.10M(+193.7%)
$8.54M(+15.1%)
$27.10M(+14.0%)
Sep 2015
-
$7.42M(+17.6%)
$23.78M(+15.2%)
Jun 2015
-
$6.31M(+30.5%)
$20.63M(+42.7%)
Mar 2015
-
$4.83M(-7.3%)
$14.46M(+56.7%)
Dec 2014
$9.22M(-1254.3%)
$5.22M(+22.0%)
$9.22M(+165.0%)
Sep 2014
-
$4.28M(+3240.8%)
$3.48M(-674.0%)
Jun 2014
-
$128.00K(-132.3%)
-$606.50K(-43.4%)
Mar 2014
-
-$396.60K(-24.6%)
-$1.07M(+98.2%)
Dec 2013
-$799.20K(+454.2%)
-$526.20K(-379.4%)
-$540.80K(+47.8%)
Sep 2013
-
$188.30K(-155.8%)
-$365.80K(-26.5%)
Jun 2013
-
-$337.40K(-350.9%)
-$497.70K(-380.7%)
Mar 2013
-
$134.50K(-138.3%)
$177.30K(-223.0%)
Dec 2012
-$144.20K(-98.2%)
-$351.20K(-722.7%)
-$144.20K(-91.9%)
Sep 2012
-
$56.40K(-83.3%)
-$1.77M(-41.8%)
Jun 2012
-
$337.60K(-280.5%)
-$3.05M(-43.0%)
Mar 2012
-
-$187.00K(-90.6%)
-$5.35M(-32.9%)
Dec 2011
-$7.97M(-15.4%)
-$1.98M(+62.4%)
-$7.97M(-5.4%)
Sep 2011
-
-$1.22M(-38.0%)
-$8.42M(-16.2%)
Jun 2011
-
-$1.97M(-29.9%)
-$10.06M(-4.3%)
Mar 2011
-
-$2.81M(+15.4%)
-$10.51M(+36.4%)
Dec 2010
-$9.42M(-13.5%)
-$2.43M(-14.8%)
-$7.71M(+46.1%)
Sep 2010
-
-$2.85M(+17.9%)
-$5.27M(+117.9%)
Jun 2010
-
-$2.42M(+32.6%)
-$2.42M(-75.3%)
Jun 2009
-
-$1.82M(-29.7%)
-$9.79M(-10.1%)
Mar 2009
-
-$2.59M(+27.3%)
-$10.89M(+34.7%)
Mar 2009
-$10.89M(+7.0%)
-
-
Dec 2008
-
-$2.04M(-38.8%)
-$8.08M(-5.8%)
Sep 2008
-
-$3.33M(+13.8%)
-$8.58M(+63.2%)
Jun 2008
-
-$2.93M(-1478.8%)
-$5.25M(+124.8%)
Mar 2008
-$10.17M(+1421.0%)
$212.20K(-108.4%)
-$2.34M(-8.9%)
Dec 2007
-
-$2.54M(>+9900.0%)
-$2.57M(+8624.8%)
Sep 2007
-
-$5000.00(-41.2%)
-$29.40K(+20.5%)
Jun 2007
-
-$8500.00(-46.5%)
-$24.40K(+53.5%)
Mar 2007
-
-$15.90K
-$15.90K
Mar 2007
-$668.80K(+4054.0%)
-
-
Dec 2006
-$16.10K
-
-

FAQ

  • What is MiMedx Group, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for MiMedx Group, Inc.?
  • What is MiMedx Group, Inc. annual EBITDA year-on-year change?
  • What is MiMedx Group, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for MiMedx Group, Inc.?
  • What is MiMedx Group, Inc. quarterly EBITDA year-on-year change?
  • What is MiMedx Group, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for MiMedx Group, Inc.?
  • What is MiMedx Group, Inc. TTM EBITDA year-on-year change?

What is MiMedx Group, Inc. annual EBITDA?

The current annual EBITDA of MDXG is $62.35M

What is the all time high annual EBITDA for MiMedx Group, Inc.?

MiMedx Group, Inc. all-time high annual EBITDA is $62.35M

What is MiMedx Group, Inc. annual EBITDA year-on-year change?

Over the past year, MDXG annual EBITDA has changed by +$21.81M (+53.80%)

What is MiMedx Group, Inc. quarterly EBITDA?

The current quarterly EBITDA of MDXG is $15.53M

What is the all time high quarterly EBITDA for MiMedx Group, Inc.?

MiMedx Group, Inc. all-time high quarterly EBITDA is $25.22M

What is MiMedx Group, Inc. quarterly EBITDA year-on-year change?

Over the past year, MDXG quarterly EBITDA has changed by -$8.68M (-35.85%)

What is MiMedx Group, Inc. TTM EBITDA?

The current TTM EBITDA of MDXG is $51.13M

What is the all time high TTM EBITDA for MiMedx Group, Inc.?

MiMedx Group, Inc. all-time high TTM EBITDA is $66.74M

What is MiMedx Group, Inc. TTM EBITDA year-on-year change?

Over the past year, MDXG TTM EBITDA has changed by -$15.35M (-23.09%)
On this page